Head-to-head · Cost-Efficiency Index
Cabana vs LovelyMeds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Cabana
Shoppers who want a lifestyle-branded concierge wellness experience bundling GLP-1 with other treatments.
Visit CabanaLovelyMeds
Shoppers who want a wide product selection (compounded + branded) and don't mind price-shopping through an intake quiz.
Visit LovelyMedsThe verdict
Cabana takes it, leading the Cost-Efficiency Index 40 to 39. Cabana is a concierge wellness brand offering compounded GLP-1 semaglutide and tirzepatide (injections and a semaglutide tablet) alongside NAD+ energy products, advertised from $249/month. LovelyMeds still earns a C — Shoppers who want a wide product selection (compounded + branded) and don't mind price-shopping through an intake quiz.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Cabana.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Cabana | LovelyMeds |
|---|---|---|
| Cost-Efficiency Index | 40/100 | 39/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #525 | #528 |
Cabana
40/100Where the value is
- Offers a semaglutide tablet option in addition to injectables
- Single, findable headline price ($249/mo starting) visible without an account
- Explicit disclaimer distinguishing FDA-approved vs. compounded (non-FDA-approved) medications
The tradeoffs
- Pricing is not broken out by specific drug or dose -- unclear what a semaglutide vs. tirzepatide patient actually pays
- 'Starting At' framing with no clarification of whether $249 is promotional or standard
LovelyMeds
39/100Where the value is
- Very broad catalog: both compounded and branded semaglutide/tirzepatide options
- Wide state coverage (excludes only 4 states: KS, LA, MS, NM)
- Multiple delivery formats offered (injection, oral drops, troche)
The tradeoffs
- No pricing disclosed anywhere on the public site
- No named medical director or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. We still list and link to LovelyMeds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.